Lumenis, the inventors of intense pulsed light (IPL) is now offering clinicians Optima IPL – “the most advanced system in market”.
With every pulse of light, this energy-based therapy works to control the inflammatory process, to stop the vicious cycle of dry eye due to MGD – displacing drops and drugs and providing long-lasting results. With no ongoing consumable costs and clinically proven outcomes, the Optima IPL offers exceptional value to clinicians looking to ‘up their dry eye game’ in 2020.
Contact: Lumenis (AUS) 1800 586 364
